The AKT1 gene is associated with attention and brain morphology in schizophrenia

World Journal of Biological Psychiatry

Volumn 14, Issue 2, 2013, Pages 100-113

  Ohi, Kazutaka ^a,b   Hashimoto, Ryota ^a,b   Yasuda, Yuka ^a,b   Fukumoto, Motoyuki ^a,b   Nemoto, Kiyotaka ^d   Ohnishi, Takashi ^e   Yamamori, Hidenaga ^a,c   Takahashi, Hidetoshi ^a,b   Iike, Naomi ^a,b   Kamino, Kouzin ^a,f   Yoshida, Tetsuhiko ^a   Azechi, Michiyo ^a   Ikezawa, Koji ^a   Tanimukai, Hitoshi ^a   Tagami, Shinji ^a   Morihara, Takashi ^a   Okochi, Masayasu ^a   Tanaka, Toshihisa ^a   Kudo, Takashi ^a   Iwase, Masao ^a   Kazui, Hiroaki ^a   Takeda, Masatoshi ^a   more..

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f Yamato Mental Medical Center   (Japan)

Author keywords

AKT1; Attention; Schizophrenia; Single nucleotide polymorphism (SNP); VBM

Indexed keywords

PROTEIN KINASE B;

ADULT; AKT1 GENE; ARTICLE; ATTENTION DISTURBANCE; BRAIN; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VOXEL BASED MORPHOMETRY; WECHSLER MEMORY SCALE;

ADULT; ATTENTION; BRAIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84874899656     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.591826     Document Type: Article

References (64)

1. Alexander GE, DeLong MR, Strick PL. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357-381. (Pubitemid 16055790)
2. Ashburner J, and Friston KJ. 2000. Voxel-based morphometry-the methods. Neuroimage 11: 805-821.
3. Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, et al. 2006. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet 141B: 383-386. (Pubitemid 43872890)
4. Balu DT, Carlson GC, Talbot K, Kazi H, Hill-Smith TE, Easton RM, et al. 2011. Akt1 defi ciency in schizophrenia and impairment of hippocampal plasticity and function. Hippocampus.
5. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, et al. 2004. Lithium antagonizes dopaminedependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099-5104. (Pubitemid 38469209)
6. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2005. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261-273. (Pubitemid 41032989)
7. Beaulieu JM, Gainetdinov RR, Caron MG. 2007a. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci 28: 166-172. (Pubitemid 46483722)
8. Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, et al. 2007b. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 27: 881-885. (Pubitemid 46174508)
9. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, et al. 2009. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54: 98-107.
10. Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, Caforio G, et al. 2011. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Proc Natl Acad Sci USA 108: 1158-1163.
11. Cardno AG, and Gottesman, II. 2000. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97: 12-17. (Pubitemid 30257322)
12. Chan RC, Di X, McAlonan GM, Gong QY. 2011. Brain anatomical abnormalities in high-risk individuals, fi rst-episode, and chronic schizophrenia: An activation likelihood estimation metaanalysis of illness progression. Schizophr Bull 37: 177-188.
13. Chen WJ, Faraone SV. 2000. Sustained attention defi cits as markers of genetic susceptibility to schizophrenia. Am J Med Genet 97: 52-57. (Pubitemid 30257326)
14. Cornblatt BA, Keilp JG. 1994. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 20: 31-46. (Pubitemid 24071091)
15. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. 1988. The Continuous Performance Test, identical pairs version (CPT-IP): I. New fi ndings about sustained attention in normal families. Psychiatry Res 26: 223-238.
16. Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L. 1989. The continuous performance test, identical pairs version: II. Contrasting attentional profi les in schizophrenic and depressed patients. Psychiatry Res 29: 65-85. (Pubitemid 19189161)
17. Ellison-Wright I, Bullmore E. 2010. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 117: 1-12.
18. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131-137. (Pubitemid 38174370)
19. Freyberg Z, Ferrando SJ, Javitch JA. 2010. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. Am J Psychiatry 167: 388-396.
20. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21-36. (Pubitemid 32552740)
21. Green MF. 2006. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67(Suppl 9): 3-8; discussion 36-42. (Pubitemid 44369648)
22. Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426. (Pubitemid 32781670)
23. Gupta A, Schulze TG, Nagarajan V, Akula N, Corona W, Jiang XY, et al. 2011. Interaction networks of lithium and valproate molec ular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. Pharmacogenom J. 12: 328-341.
24. Harris SL, Gil G, Robins H, Hu W, Hirshfi eld K, Bond E, et al. 2005. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci USA 102: 16297-16302. (Pubitemid 41688908)
25. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, et al. 2006. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15: 3024-3033. (Pubitemid 44530706)
26. Hashimoto R, Hashimoto H, Shintani N, Chiba S, Hattori S, Okada T, et al. 2007. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 12: 1026-1032. (Pubitemid 350006203)
27. Horwood JM, Dufour F, Laroche S, Davis S. 2006. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 23: 3375-3384.
28. Ide M, Ohnishi T, Murayama M, Matsumoto I, Yamada K, Iwayama Y, et al. 2006. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem 99: 277-287. (Pubitemid 44395150)
29. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. 2004. Association of AKT1 with schizophrenia confi rmed in a Japanese population. Biol Psychiatry 56: 698-700. (Pubitemid 39446853)
30. Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S, et al. 2008. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in fi rst-episode schizophrenia. Pharmacogenomics 9: 1437-1443.
31. Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS. 2004. The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett 560: 115-119. (Pubitemid 38264303)
32. Karege F, Perroud N, Schurhoff F, Meary A, Marillier G, Burkhardt S, et al. 2010. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder. Genes Brain Behav 9: 503-511.
33. Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, et al. 2006. Akt1 defi ciency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA 103: 16906-16911. (Pubitemid 44737351)
34. Lee KY, Joo EJ, Jeong SH, Kang UG, Roh MS, Kim SH, et al. 2010. No association between AKT1 polymorphism and schizophrenia: a case-control study in a Korean population and a meta-analysis. Neurosci Res 66: 238-245.
35. Lin CH, Yeh SH, Lu KT, Leu TH, Chang WC, Gean PW. 2001. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31: 841-851.
36. Liu YL, Fann CS, Liu CM, Wu JY, Hung SI, Chan HY, et al. 2006. Absence of signifi cant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr Genet 16: 39-41. (Pubitemid 44481219)
37. Mathur A, Law MH, Megson IL, Shaw DJ, Wei J. 2010. Genetic association of the AKT1 gene with schizophrenia in a British population. Psychiatr Genet 20: 118-122.
38. Meyer-Lindenberg A, Weinberger DR. 2006. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7: 818-827. (Pubitemid 44435264)
39. Mizuno M, Yamada K, Takei N, Tran MH, He J, Nakajima A, et al. 2003. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol Psychiatry 8: 217-224. (Pubitemid 36315230)
40. Norton N, Williams HJ, Dwyer S, Carroll L, Peirce T, Moskvina V, et al. 2007. Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr Res 93: 58-65. (Pubitemid 46817938)
41. Ohtsuki T, Inada T, Arinami T. 2004. Failure to confi rm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry 9: 981-983.
42. Pantelis C, Barnes TR, Nelson HE, Tanner S, Weatherley L, Owen AM, et al. 1997. Frontal-striatal cognitive defi cits in patients with chronic schizophrenia. Brain 120(Pt 10): 1823-1843. (Pubitemid 27443056)
43. Pietilainen OP, Paunio T, Loukola A, Tuulio-Henriksson A, Kieseppa T, Thompson P, et al. 2009. Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins. Am J Med Genet B Neuropsychiatr Genet 150B: 683-692.
44. Pinheiro AP, Keefe RS, Skelly T, Olarte M, Leviel K, Lange LA, et al. 2007. AKT1 and neurocognition in schizophrenia. Aust NZ J Psychiatry 41: 169-177. (Pubitemid 46705630)
45. Salgado-Pineda P, Junque C, Vendrell P, Baeza I, Bargallo N, Falcon C, et al. 2004. Decreased cerebral activation during CPT performance: structural and functional defi cits in schizophrenic patients. Neuroimage 21: 840-847. (Pubitemid 38314945)
46. Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C, et al. 2008. No signifi cant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 165: 497-506. (Pubitemid 351694293)
47. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. 2005. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58: 446-450. (Pubitemid 41393606)
48. Sei Y, Li Z, Song J, Ren-Patterson R, Tunbridge EM, Iizuka Y, et al. 2010. Epistatic and functional interactions of catechol-omethyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models. PLoS One 5: e10789.
49. Shi J, Gershon ES, Liu C. 2008. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 104: 96-107.
50. Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. 2008. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophr Res 105: 78-85.
51. Snitz BE, Macdonald AW, 3rd, Carter CS. 2006. Cognitive defi cits in unaffected fi rst-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 32: 179-194. (Pubitemid 43063833)
52. Sugishita M. 2001. Japanese Wechsler Memory Scale-Revised . Tokyo: Nihonbunkakagakusha.
53. Sui L, Wang J, Li BM. 2008. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn Mem 15: 762-776.
54. Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z. 2008. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet 147B: 1173-1181.
55. Tan HY, Callicott JH, Weinberger DR. 2008a. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Mol Psychiatry 13: 233-238. (Pubitemid 351272661)
56. Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R, et al. 2008b. Genetic variation in AKT1 is linked to dopamineassociated prefrontal cortical structure and function in humans. J Clin Invest 118: 2200-2208. (Pubitemid 351872338)
57. Thiselton DL, Vladimirov VI, Kuo PH, McClay J, Wormley B, Fanous A, et al. 2008. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 63: 449-457. (Pubitemid 351220788)
58. Tsuang M. 2000. Schizophrenia: genes and environment. Biol Psychiatry 47: 210-220. (Pubitemid 30077397)
59. Turunen JA, Peltonen JO, Pietilainen OP, Hennah W, Loukola A, Paunio T, et al. 2007. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res 91: 27-36. (Pubitemid 46335850)
60. Wechsler D. 1987. Wechsler Memory Scale Manual, Revised. San Antonio, TX: Psychological Corporation.
61. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. 2001a. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50: 825-844. (Pubitemid 34020697)
62. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. 2001b. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50: 825-844. (Pubitemid 34020697)
63. Xu MQ, Xing QH, Zheng YL, Li S, Gao JJ, He G, et al. 2007. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J Clin Psychiatry 68: 1358-1367. (Pubitemid 47524515)
64. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, et al. 2007. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104: 20552-20557.